These results, along with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 aid the thought of targeting ACKR3 as a novel way to modulate the opioid method, which could open new therapeutic avenues for opioid-linked disorders. We independently research, overview, and advocate https://stepheny839lua8.blogsvirals.com/profile